InvestorsHub Logo
icon url

DougS.

07/10/03 6:30 PM

#1051 RE: bag7ger #1048

Bag - from what I've read, Ancestry 3.0 is definitely in progress. The samples are expensive and there are many more groups now but the process is exactly the same as 2.0.

As we learned with Retinome, chips are better suited for complex tests but they can also be prohibitively expensive. Usually a company has the option of weighing performance vs. cost when marketing a product. But in this case, I don't think performance can be compromised. So it boils down to cost.

So I'm interested to see how this unfolds - which chip supplier they use, whether they can get it down to a marketable cost and if it will be the first DNAP product to achieve the coup d'etat in genetics testing that many of us have been waiting for.

Something to consider: Ancestry 3.0, whenever it comes out, can be marketed to many geographic regions that 2.0 cannot. Genetic/cultural stratification is a universal condition.